Canopy Growth Corp CGC
Canopy Growth Corp (Nasdaq: CGC) is a cannabis-derived therapeutics company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Recent results and decisions
- Oct 14, 2026n/a Canopy Growth received a Nasdaq deficiency notice for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, with 180 days to regain compliance by April 12, 2027.
The Company has 180 calendar days from the date of the Letter, or until April 12, 2027 (the 'Compliance Period'), to regain compliance with respect to the Minimum Bid Price Requirement.
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.